
Brand Name | Status | Last Update |
|---|---|---|
| acts38 boswelliagel | unapproved drug other | 2022-09-07 |
| acts38 boswelliagel (100ml) | unapproved drug other | 2022-10-22 |
| ascorbyl palmitate 2% / hyaluronic acid sodium salt 0.2% / niacinamide 5% / tretinoin 0.025% | unapproved drug other | 2019-05-17 |
| calcipotriene 0.005% / diclofenac sodium 3% / hyaluronic acid sodium salt 2% / niacinamide 2% | unapproved drug other | 2019-05-06 |
| clapiel hyalon serum | unapproved drug other | 2015-07-24 |
| cotta | unapproved drug other | 2013-07-08 |
| curithys | unapproved drug other | 2021-12-01 |
| deepair micro intensive magic | unapproved drug other | 2016-09-18 |
| diclofenac sodium 3% / hyaluronic acid sodium salt 2% / niacinamide 4% | unapproved drug other | 2019-05-06 |
| dr.plinus fillincell multi | unapproved drug other | 2022-10-18 |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Acute pain | D059787 | — | R52 | 1 | — | — | — | — | 1 |
| Drug common name | Hyaluronate sodium |
| INN | _ |
| Description | Hyaluronate sodium is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | — |
| PDB | — |
| CAS-ID | 9004-61-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL4594244 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | YSE9PPT4TH (ChemIDplus, GSRS) |

